Michiko Nagamine MD
Cytopathology, Anatomic Pathology, Clinical Pathology
Physician
Join to View Full Profile
800 Spruce StPhiladelphia, PA 19107
Phone+1 215-829-5933
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michiko Nagamine, MD is a board certified pathologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Nevada and California.
Education & Training
Pennsylvania Hospital (UPHS)Residency, Pathology-Anatomic and Clinical, 2007 - 2009
Berkshire Medical CenterResidency, Pathology-Anatomic and Clinical, 2002 - 2004
Certifications & Licensure
CA State Medical License 2009 - 2016
NV State Medical License 2010 - 2013
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 1 citationsSolid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in-Mutated Lung Adenocarcinoma.Yuji Uehara, Hiroki Izumi, Tetsuro Taki, Tetsuya Sakai, Hibiki Udagawa
JTO Clinical and Research Reports. 2025-03-01 - Prognostic value of the international association for the study of lung cancer grading system and its association with the tumor microenvironment in stage I EGFR-muted...Shoko Kubota, Tetsuro Taki, Tomohiro Miyoshi, Kenta Tane, Joji Samejima
European Journal of Cancer. 2024-08-01 - Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern.Eisuke Goto, Tetsuro Taki, Kotaro Nomura, Yuko Miyakami, Tomohiro Miyoshi
Lung Cancer. 2024-06-01
